MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.1354
-0.0056 (-3.97%)
Sep 18, 2025, 10:43 AM EDT
MariMed Market Cap
MariMed has a market cap or net worth of $55.43 million as of September 18, 2025. Its market cap has decreased by -21.50% in one year.
Market Cap
55.43M
Enterprise Value
149.24M
Revenue
157.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since May 12, 2017, MariMed's market cap has increased from 25.70M to 55.43M, an increase of 115.70%. That is a compound annual growth rate of 9.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 55.43M | 25.48% |
| Dec 31, 2024 | 44.17M | -57.26% |
| Dec 29, 2023 | 103.36M | -14.51% |
| Dec 30, 2022 | 120.90M | -58.11% |
| Dec 31, 2021 | 288.61M | 101.45% |
| Dec 31, 2020 | 143.26M | 3.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| CytoDyn | 351.92M |
| American Oncology Network | 345.48M |